HRTS ETF Price & Analysis
HRTS ETF Chart & Stats
$32.79
--
Market closed
$32.79
--
Day’s Range― - ―
52-Week Range$25.32 - $36.65
Previous Close$32.79
VolumeN/A
Average Volume (3M)7.41K
AUM50.86M
NAV32.83
Expense Ratio0.75%
Holdings Count46
Beta0.78
Inception DateNov 21, 2023
Last Dividend Ex-Date
Dec 10, 2025Dividend Yield
(1.44%)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume2,397
30 Day Avg. Volume7,407
AlphaN/A
ETF Overview
Tema Cardiovascular and Metabolic ETF
The Tema Cardiovascular and Metabolic ETF (Ticker: HRTS) is a specialized exchange-traded fund designed to provide investors with targeted exposure to the innovative and rapidly evolving sectors within the health care industry. Focusing on the Pharma, Biotech & Life Sciences niche, this ETF is dedicated to companies at the forefront of cardiovascular and metabolic health advancements. It seeks to capture the growth potential of firms pioneering treatments, technologies, and research aimed at combating prevalent health issues such as heart disease, diabetes, and other metabolic disorders. By investing in HRTS, investors gain access to a curated portfolio of leading-edge companies that are shaping the future of health care, driving significant improvements in patient outcomes, and potentially transforming the landscape of medical science. This sector-focused ETF is an ideal choice for those looking to capitalize on the intersection of healthcare innovation and market opportunity in the cardiovascular and metabolic domains.
Tema Cardiovascular and Metabolic ETF (HRTS) Fund Flow Chart
Tema Cardiovascular and Metabolic ETF (HRTS) 1 year Net Flows: -$15M
HRTS ETF News
HRTS ETF FAQ
What was HRTS’s price range in the past 12 months?
HRTS lowest ETF price was $25.32 and its highest was $36.65 in the past 12 months.
What is the AUM of HRTS?
As of Mar 20, 2026 The AUM of HRTS is 50.86M.
Is HRTS overvalued?
According to Wall Street analysts HRTS’s price is currently Undervalued.
Does HRTS pay dividends?
HRTS pays a Notavailable dividend of $0.473 which represents an annual dividend yield of 1.44%. See more information on HRTS dividends here
How many shares outstanding does HRTS have?
Currently, no data Available
Which hedge fund is a major shareholder of HRTS?
Currently, no hedge funds are holding shares in HRTS
HRTS ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Eli Lilly And Company
9.49%
Roche Holding AG
4.83%
Johnson & Johnson
4.80%
AstraZeneca plc
4.74%
Merck & Company
4.25%
Unitedhealth Group Inc.
4.00%
Thermo Fisher Scientific
3.92%
Gilead Sciences
3.73%
Novartis
3.44%
Abbott Laboratories
3.38%
Total46.56%
See All Holdings